Becerra warns mifepristone case could open door to challenges against other approvals
Regulatory NewsFerdous Al-Faruque
Advanced therapies/cell and gene therapyAPIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsCosmeticsDiagnostics/IVDsDigital health/SaMD/AIGenericsMedical DevicesNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/PolicyUnited States